Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 67   

Articles published

AZN 4,570.00 +5.00 (0.11%)
price chart
AstraZeneca Is Undervalued
AstraZeneca plc is a global biopharmaceutical company. AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and ...
Amylin Said to Attract Interest From Pfizer, AstraZeneca
AstraZeneca Plc (AZN), the U.K.'s second-biggest drugmaker, shouldn't get a further reduction in an antitrust fine of 52.5 million euros ($67.5 million), an adviser to the European Union's highest court said.
EU adviser backs antitrust fine for AstraZeneca  Reuters UK
Related articles »  
Analyst Insights: Finish Line, BioMarin Pharma, Laboratory Corp, Ocz ...
AstraZeneca PLC (NYSE:AZN): Leerink expects AstraZeneca (NYSE:AZN) to appoint a new CEO over the next six months and thinks the person should be aggressive on acquisitions.
Related articles »  
GSK rejects idea of buying AstraZeneca
LONDON (Reuters) - Britain's biggest drug maker GlaxoSmithKline (GSK.L) has no interest in buying smaller rival AstraZeneca (AZN.L), GSK's chief executive said on Thursday in response to a shareholder question at the company's annual meeting.
Related articles »  
William Hill stands by CEO amid shareholder revolt
William Hill (WMH) was the latest company to respond to shareholder outrage over executive pay. The bookmaking giant rushed to the defence of chief executive Ralph Topping's �1.2 million bonus on Tuesday as it countered the shareholder rebellion at its ...
William Hill chief Ralph Topping narrowly wins pay vote  Telegraph.co.uk
Related articles »  
Aviva chief resigns after shareholder uprising
The resignation of Moss followed the high-profile exits of Sly Bailey from Trinity Mirror and David Brennan from AstraZeneca last week as a result of shareholder hostility. Aviva shares, which have fallen a third in a year, were up 4% on the news. Lord ...
Related articles »  
Shareholder spring: After the unseating of big beasts, no overpaid executive ...
Sly Bailey of Trinity Mirror and David Brennan of AstraZeneca have been defenestrated due to a toxic mix of large rewards and lacklustre returns.
Related articles »  
Barclays' BlackRock timing
For the record, the 2011 reports of companies embroiled in significant recent pay-related rows record their advisers as follows: AstraZeneca - Deloitte; Barclays - Towers Watson; Cairn Energy - Hewitt New Bridge Street; and Prudential - Deloitte.
Related articles »  
EU to push for binding investor pay votes
Shareholders in Europe's listed companies will be given a binding vote on pay while those who invest in banks will gain powers to set a cap on bonus levels, under plans being drawn up by senior EU officials.
Lilly, Jaguar Land Rover, Viacom: Intellectual Property
Eli Lilly & Co. (LLY) and AstraZeneca Plc (AZN) won't have an easier time gaining more of the market for blood thinners dominated by Bristol-Myers Squibb Co.
Related articles »